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Tricho-rhino-phalangeal syndrome (TRPS) is characterized by craniofacial and skeletal abnormalities, 
and subdivided in TRPS I, caused by mutations in TRPS1, and TRPS II, caused by a contiguous gene 
deletion affecting (amongst others) TRPS1 and EXT1. We performed a collaborative international study 
to delineate phenotype, natural history, variability, and genotype - phenotype correlations in more 
detail.  
We gathered information on 103 cytogenetically or molecularly confirmed affected individuals. TRPS I 
was present in 85 individuals (22 missense mutations, 62 other mutations), TRPS II in 14, and in 5 it 
remained uncertain whether TRPS1 was partially or completely deleted.   
Main features defining the facial phenotype include fine and sparse hair, thick and broad eyebrows, 
especially the medial portion, a broad nasal ridge and tip, underdeveloped nasal alae, and a broad 
columella. The facial manifestations in patients with TRPS I and TRPS II do not show a significant 
difference. In the limbs the main findings are short hands and feet, hypermobility, and a tendency for 
isolated metacarpals and metatarsals to be shortened. Nails of fingers and toes are typically thin and 
dystrophic. The radiological hallmark are the cone-shaped epiphyses and in TRPS II multiple exostoses. 
Osteopenia is common in both, as is reduced linear growth, both prenatally and postnatally. 
Variability for all findings, also within a single family, can be marked. 
Morbidity mostly concerns joint problems, manifesting in increased or decreased mobility, pain and in 
a minority an increased fracture rate. The hips can be markedly affected at a (very) young age. 
Intellectual disability is uncommon in TRPS I and, if present, usually mild. In TRPS II intellectual 
disability is present in most but not all, and again typically mild to moderate in severity.  
Missense mutations are located exclusively in exon 6 and 7 of TRPS1. Other mutations are located 
anywhere in exons 4-7. Whole gene deletions are common but have variable breakpoints. Most of the 
phenotype in patients with TRPS II is explained by the deletion of TRPS1 and EXT1, but 
haploinsufficiency of RAD21 is also likely to contribute. Genotype-phenotype studies showed that 
mutations located in exon 6 may have somewhat more pronounced facial characteristics and more 
marked shortening of hands and feet compared to mutations located elsewhere in TRPS1, but 
numbers are too small to allow firm conclusions.   
 
Keywords: tricho-rhino-phalangeal syndrome; TRPS; Langer-Giedion syndrome; TRPS1; multiple 
exostoses; EXT1; RAD21; natural history; genotype; phenotype; review  
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INTRODUCTION 
 
The first description of individuals with sparse hair, an unusual face predominantly in the shape of the 
nose, and anomalies of the distal limbs was published by the Dutch physician Van der Werff ten Bosch in 
1959 [Van der Werff ten Bosch 1959]. Other early possible descriptions may have been those of Keizer 
and Schilder [1951], Klingmüller [1956], and Alé and Caló [1961]. In 1966 Andres Giedion reported 
several individuals with this constellation of manifestations of whom one male had in addition, multiple 
exostoses and intellectual disability [Giedion, 1966]. He suggested naming the entity tricho-rhino-
phalangeal syndrome (TRPS). Leonard Langer [Langer, 1969] described almost simultaneously with 
Robert Gorlin and co-workers [Gorlin et al., 1969] affected individuals who also had developmental delay 
and multiple exostoses. Hall and co-workers [Hall et al., 1974] suggested subdivision of TRPS into TRPS I 
(OMIM 190350) for individuals with normal development and absent exostoses, and TRPS II or Langer-
Giedion syndrome (OMIM 150230) for those with intellectual disability and exostoses. 
The identification of an interstitial deletion involving chromosome 8q24 in an individual with 
TRPS II [Bühler et al., 1984] and subsequently a balanced translocation involving 8q24.1 in two 
individuals with TRPS I [Marchau et al., 1993] were the first steps in the localisation of the entities. In 
2000 mutations in the zinc finger transcription factor TRPS1 were described in TRPS I [Momeni et al., 
2000]. TRPS II was proposed as a contiguous gene deletion syndrome involving both TRPS1 and the gene 
for multiple hereditary exostoses EXT1 [Bühler et al, 1987; Lüdecke et al., 1995]. The rare recurrences of 
TRPS in sibs of healthy parents [Hussels 1971; Jüngst and Spranger, 1976; Van Neste and Dumortier, 
1982] is most likely explained by germ-line or somatic mosaicism.  
Some authors have proposed another subtype, TRPS III (OMIM 190351), associated with more 
marked growth impairment and shortening of fingers and toes [Niikawa and Kamei, 1986]. The 
differences between TRPS I and TRPS III are small, and may merely represent a spectrum of severity with 
some evidence of a genotype-phenotype correlation for specific mutations in TRPS1 [Lüdecke et al., 
2001]. 
There are only limited data available on genotype – phenotype correlations. The study by 
Lüdecke and co-workers on 51 unrelated TRPS patients in which they were able to detect 35 different 
mutations in 44 patients is the most informative one [Lüdecke et al., 2001]. A recent review of the 
(sparse) literature on adults with this syndrome, including one of the first patients described by Giedion, 
is also very useful [Schinzel et al., 2013]. Here we report on a series of 103 individuals with TRPS 
gathered through an international collaborative study. We present data on the major clinical 
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manifestations, natural history, interfamilial and intra-familial variability, and genotype - phenotype 
correlations.  
 
 
PATIENTS AND METHODS 
 
Acquisition and Phenotype 
We asked all physicians attending the 2013 European Course on Dysmorphology, and their local 
colleagues, to send us clinical information of all TRPS patients known to them. We used a dedicated 
questionnaire to retrieve data. To these data we added the data from an earlier study of all individuals 
with TRPS known to the UK TRPS Support group, performed 2007-2010 by two of us (ACS; RCH). 
Available clinical pictures and X-rays of all affected individuals were obtained. These were scored 
independently by the first (SMM) and senior author (RCH). In case of discrepancies the differences were 
discussed until consensus was reached. In case a clinical feature could not be scored reliably from 
available pictures it was not scored at all. Data were stored in Excel. 
 
Genotype 
The genotype was obtained either from literature if patients had been published [Rocha Carvalho et al., 
2011; Schinzel et al., 2013; Chen et al., 2013; Plaza-Benhumea et al., 2014], or the referring clinician. In 
the majority of patients, DNA had been analysed at the University Hospital in Essen, Germany (HJL). A 
number of laboratories and various techniques had been used including FISH (single probe or series of 
probes), MLPA and Sanger sequencing. Due to the variable methodologies used, the annotation of the 
breakpoints of some deletions remain approximate. If the genotype was unknown, TRPS1 was analysed 
by the molecular genetics diagnostic laboratory of the Academic Medical Centre in Amsterdam (HB) 
using standard Sanger sequencing. Annotation was according to reference sequence NM_014112.4. We 
grouped mutations into three categories: those with deletions encompassing TRPS1 completely, those 
with missense mutations, and those with other mutations such as frameshift mutations, nonsense 
mutations, and intragenic deletions. In 5 individuals a deletion was proven but the size of the deletion 
remained uncertain and it could not be excluded the whole gene was deleted. In the tabulations and 
discussions these were not included in one of the subgroups but were included in the total group. 
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RESULTS 
 
We present the results of studies in 103 patients including ninety-six patients that have not been 
published before, and seven that have been published [Rocha Carvalho et al., 2011; Schinzel et al., 2013; 
Chen et al., 2013; Plaza-Benhumea et al., 2014]. The clinical data are presented in Tables I-IV and 
illustrated in Figs. 1-9 and 11. The genotypes are summarized in Table V and illustrated in Fig.10. We 
provide figures both for the TRPS I patients with missense mutations, those with all other causes of TRPS 
I, TRPS II patients with whole gene deletions, and all TRPS cases together. In the text we mention only 
these data that are not presented in the tables or figures . 
 
Phenotype 
The general phenotype is easily recognisable from Table III and Figs. 1-8. An unusually blond hair colour, 
mentioned several times in the literature, is difficult to validate as data on familiar hair colour were not 
collected. The broadening and sometimes also thickening of the eyebrows is typically limited to the 
median one-third. In some the median part of the eyebrows is normally formed while the middle and 
distal part are underdeveloped. Four patients have a broad chin with a horizontal crease.  
 
Growth, development, and natural history 
Linear growth is decreased in almost all patients, both prenatally and postnatally, and falls below the 
third centile in half of the adult patients. The percentage of TRPS I individuals with intellectual disability 
is similar to that in the general population, but mild to moderate intellectual disability occurs in two-
third of the TRPS II patients. Delay in motor development is usually associated with hip dysplasia and 
therefore likely to be secondary.  
Seizures are uncommon, and consist of febrile convulsions in childhood and grand mal seizures in 
a small number of adult TRPS II patients. Myopia is by far the most frequent vision disturbance in all 
groups but in total visual disturbances are not common. Infrequently, hypermetropia, astigmatism, optic 
disc atrophy and strabismus are reported. In one patient stenosis of the lacrimal ducts needed surgery. 
Hearing impairment is common but mild in all patients, and is frequently secondary to serous 
otitis media. Dental overcrowding is commonly reported, and a small number of patients report delayed 
eruption of the primary dentition. Microdontia is also reported albeit infrequently.  
Cardiac abnormalities are more common than in the general population, are variable in all 
groups of TRPS patients, and range from minor anomalies such as persistent ductus arteriosus, persistent 
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foramen ovale, bicuspid aortic valve, and mitral valve prolapse/regurgitation, to more significant 
problems such as aortic stenosis, anomalous pulmonary venous return and left heart insufficiency. A 
single TRPS I patient reports WPW syndrome, another TRPS I patient grade 2 AV block, and a TRPS II 
patient has a dilated aortic root. Respiratory problems consist mainly of recurrent upper and lower 
airway infections in the TRPS II patients. In TRPS I patients, both with missense mutations and other 
genotypes, the most frequent complaint is asthmatic bronchitis, occurring in 12 patients. There is one 
child and one adult with obstructive sleep apnoea. Infections in TRPS II patients are limited to the 
airways, and in TRPS I patients also recurrent cystitis is noted in 7 patients. No patient reports include 
data on investigations for immunological disturbances. Gastro-oesophageal reflux is more commonly 
described in TRPS II patients and is also present in adults. Renal problems are uncommon, and if present 
consist of hydronephrosis, unilateral underdeveloped kidney, and vesico-ureteral reflux. One patient 
developed nephrolithiasis. In the present group one patient has a history of imperforate hymen and 
severe vaginal stenosis, another has bicornuate uterus. 
The most significant morbidity in the present cohort is related to the joints, including increased 
or decreased mobility, joint pain and an increased fracture rate in some. Pain most commonly affects 
hips and distal extremities, but other joints are affected at lower frequencies. Complaints let to joint 
replacement (shoulder,  knees, finger) in 4 individuals. Hip dysplasia is documented in childhood in some, 
but puberty or early adulthood is more common. Hip replacement had been done as early as 33 years of 
age. Joint hypermobility is not only frequent but  can also be marked. Indeed several patients were 
referred because of the hypermobility. All reported fractures occur after puberty. One TRPS II patient has 
hemivertebrae, another has a large cystic-like lucency affecting one humerus. A single case has a 
duplicated thumb. Dislocation of the patella is reported, but in only one individual the patella is 
considered small. Radial and /or ulnar deviation of fingers is very common. A single patient has 
cutaneous syndactyly between the first and second toe, and in two patients there is cutaneous 
syndactyly between the second and third toe. The X-ray findings mirror these clinical findings.  Four 
patients have pectus carinatum, three have pectus excavatum, and four have an umbilical hernia. The 
cone-shaped epiphyses are mostly detected in the medial phalanx of the second finger, and next in the 
medial phalanx of the fifth finger. However, the variation, also within a family, is significant and cone-
shape epiphyses may also be confined to the proximal phalanges. They are much more common in finger 
phalanges compared to toe phalanges.  Likely due to the dysplasia of the epiphyses the length of the 
phalanges and metacarpals/metatarsals can change considerably. Exostoses occur exclusively in TRPS II 
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patients (Fig. 9). Numbers vary from a few to >200, and localisation is as typically seen in multiple 
exostoses (OMIM #133700).   
Three patients have a past history of cancer (thyroid cancer in one, mamma carcinoma in 
another, unspecified in the third). Hyperthyroidism is reported in two individuals. In three patients an 
unusually deep voice is noted. A single patient has a history bipolar affective disorder, and another an 
anxiety disorder. In a single TRPS II patient polymicrogyria was detected at MRI of the brain with 
associated delayed myelination, small callosal body, and dilated ventricles. A single patient has 
lymphedema, another growth hormone deficiency necessitating replacement therapy, one has 
dyspraxia, one a spinal cord injury leading to spastic paresis of the lower limbs, one an arterio-venous 
malformation of the left middle cerebral artery, one a epidermoid cyst of a buttock, one cyclic vomiting 
starting in early infancy, and two have systemic lupus erythematosus. In 10 patients across all TRPS 
types, an apparent premature aging of the skin is reported.  
 
 
Genotype 
 Most of the mutations are nonsense and frameshift mutations which can be located anywhere in exons 
4-7 of the gene (Table V; Fig. 10). The size of the deletions vary considerably and there are no common 
breakpoints. Missense mutations occur exclusively in exons 6 and 7 with the vast majority in exon 6. The 
number of recurrent mutations is very low (Table V). 
We evaluated whether the sites of mutations within the gene correlates with the main findings 
of TRPS, by comparing the frequency of signs and symptoms and the exon involved. There is no 
difference in frequency or degree of intellectual disability depending on the site of the mutation, and 
also growth and joint involvement is similar across the various mutation sites. There is a tendency for 
facial manifestations, especially eyebrow signs, to be more marked in mutations located in exon 6 
compared to mutations located elsewhere, and also shortening of metacarpal and metatarsal bones is 
somewhat more pronounced when a mutation is located in exon 6. This is irrespective of the type of 
mutation. Data have to be evaluated with care however as numbers were small and no statistically 
significant conclusions could be drawn. Apparent associations may in fact only be coincidence as well.  
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DISCUSSION 
The summary of the clinical data of this cohort and exact figures for signs and symptoms of TRPSI and II 
are presented in the Tables. These data are summarised below to provide a description of the general 
features of TRPS in the present series. 
 We do stress here that patient acquisition was through physicians who provided data on TRPS 
individuals referred to them because of complaints. It is likely this has caused a bias towards individuals 
with more marked manifestations of TRPS. It may well be that a population survey would allow 
recognition of TRPS in individuals with much less marked symptomatology. Therefore the summary 
below may not be valid for the total group of individuals with TRPS. Still we hope it will provide some 
information to affected individuals, their families, and caregivers regarding manifestations and natural 
history of TRPS, and provides initial guidance for optimal care. 
 
Growth 
Impaired growth is common in TRPS, especially in the deletion patients, but it is not universally 
expressed. It is more marked postnatally than prenatally. Adult patients with nonsense/frameshift 
mutations are slightly smaller than those with missense mutations but neither group are as small as 
patients with TRPSII deletions who all fall below the -2SD.  It has been hypothesized that this is related to 
the role of TRPS1 as regulator of histone deacetylation. Indeed, loss of trps1 in mice leads to an 
increased proportion of cells arrested in mitosis [Wuelling et al., 2014]. Body weight is usually normal in 
relation to height. Head circumference is typically normal throughout life, except for those with a 
genomic deletion in whom in one-third head circumference falls below the 3rd percentile. Growth 
hormone studies have yielded variable results, as was the reaction in growth of growth hormone therapy 
[Merjaneh et al., 2014]. 
 
Development 
If all TRPS individuals are taken together cognition is mentioned to be mild to moderately delayed in 
~15%. In the group of individuals with missense mutations the frequency is similar to that in the general 
population, in the group of other mutations it seems slightly elevated. There may be a bias however, in 
favour of reporting a developmental delay or learning difficulty, and so cognitive ability in TRPS I could 
be normal. A single member of the cohort with TRPS I has severe developmental delay, but there were 
additional environmental factors unrelated to TRPS I to explain this. In the deletion group there is a clear 
increased rate of intellectual disability. This is mirrored in the age at which motor milestones are reached 
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and first words are spoken. The developmental delay in TRPS II does not correlate with the size of the 
deleted segment in the present study group, as has been reported before [Schinzel et al., 2013]. 
 
Natural history 
The main long-term morbidity associated with TRPS are the early osteoarthritis-like changes affecting the 
large joints, especially the hips, leading to pain and decreased mobility from adolescence or early 
adulthood. Radiological features include joint dysplasia, sclerotic bone and reduced joint space. Not 
infrequently a hip prosthesis is implanted as early as at 30 years of age. Such prostheses will require 
revision (possibly more than once) due to their limited lifespan. Obtaining functional improvement 
through prosthetic joint surgery can be challenging due to longstanding adaptation and disordered 
anatomy elsewhere. Mobility problems in the small joints, especially hands, occur typically at a 
somewhat later age, usually evident in decreased mobility and pain. Due to location and nature of the 
complaints they can be mistaken for rheumatoid arthritis. Cardiac and respiratory problems are not 
common, although asthmatic bronchitis may be more frequent than expected. Problems with other 
internal organs are occasionally seen. Vision and hearing disturbances are not more frequently disturbed 
than in the general population. 
 
Face 
The facial characteristics in TRPS I and II are very similar. There are slight differences between the various 
groups in Table 2 but these become mainly clear in the relative frequency of manifestations: in an 
individual patient it will usually be impossible to make a distinction based on facial characteristics only. 
The most characteristic facial sign in TRPS is the shape and size of the nose (Fig. 3): it is large, with a 
somewhat broad ridge but especially a broad tip, underdeveloped alae, and in some a very broad 
septum that is hardly seen in the general population or other disorders. The philtrum is long and 
featureless. Patients with missense mutations seem to have a long philtrum less often. The thin upper 
vermilion becomes especially evident when the patient smiles: there is typically a horizontal smile, 
reported in the majority of the patients, and resembling the smile in Floating-Harbor syndrome (Nikkel et 
al., 2013). The resemblance with the latter becomes even more marked as the shape of the nose 
between these two syndromes look alike. Micrognathia is not common. Large and prominent ears can be 
present but most presently reported individuals had a normal ear shape (Fig. 5).  
 
Hair and nails  
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Almost all patients have fine hair that is also sparse from young age on (Fig. 1). Especially the fronto-
temporal areas become early sparsely implanted or completely bald. The hair can also be brittle and 
grows slowly. One-third of male patients lose their hair completely or almost completely at or soon after 
puberty. There are also TRPS individuals with only mild sparseness and hair growth and implantation can 
also improve with time. In women sparseness is typically less marked. Main manifestation in adult 
females is a high frontal hairline. Hair colour is frequently light but the present data cannot confirm 
whether this is more frequent than expected. The eyebrows are typically densely implanted (thick) and 
broad (Fig. 2). Broad eyebrows are more common in individuals with TRPS II compared to the other TRPS 
groups. There can be a marked difference within the various parts of an eyebrow: the medial part is 
almost invariably more densely implanted and broader than the middle or lateral parts. This difference in 
density and broadness is present when the middle and lateral part seem normally formed but also when 
these are more sparse and thin.  
Nails are thin and dystrophic in about half of all TRPS individuals. This is typically more frequent 
in the nails of the toes compared to the finger nails. 
 
Limbs 
Short hands and feet are common in all types of TRPS (Figs. 6-7). In the present groups the brachydactyly 
and shortening of the metacarpals and metatarsals was more common in the TRPS I individuals with a 
missense mutation. The shortening can be either of single metacarpal or metatarsal, which most 
commonly are the 4th and 5th but also not infrequently the 2nd rays, but also all metacarpals and 
metatarsals can be involved. The variation within a family can be significant (Fig. 11). Indeed the marked 
shortening of all metacarpals and metatarsals, earlier reported to constitute a separate type of TRPS 
[Niikawa and Kamei, 1986] can be seen in one family member while another has only mild shortening of 
some metacarpals and metatarsals, confirming the earlier suggestion that the so-called TRPS III in fact is 
a marked form of TRPS I [Lüdecke et al., 2001].  
In the present series one published patient [Carvalho et al., 2011] has TRPS II and tibial 
hemimelia caused by a deletion of 8q23.1q24.12. Two other patients with TRPS II and tibial hemimelia 
have been published [Stevens and Moore, 1999; Turleau et al., 1982]. It has been suggested that a gene 
causing tibial hemimelia may be located near TRPS1, and EXT1, which is sustained that limb anomalies 
consisting of tibial hemimelia and other abnormalities is located on the mouse homologous chromosome 
region of 9A1-A4 [Stevens and Moore, 1999]. 
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Radiologic findings 
Almost all patients have cone-shaped epiphyses, which can be detected also at an early age when 
epiphyses are just being formed. They are most frequently present in the middle phalanges but also in 
the proximal phalanges but to a lesser extent in the distal phalanges (Fig. 8). They can be symmetrical or 
asymmetrical on both sides, and there is not necessarily a correlation between the existence of cone-
shaped epiphyses in the hands and feet. Due to the abnormal shape of the epiphyses the more distal 
bone parts can be in an abnormal position, which causes the radiological (and clinical) deviation to the 
ulnar or radial side.  
Osteopenia may be present in all TRPS types, but is likely more common in TRPS II individuals. 
TRPS1 has been shown to bind through a GATA binding sequence in the proximal promoter of the 
osteocalcin gene, suggesting a role in osteoblast differentiation and possible a mechanism leading to 
osteopenia in TRPS individuals [Piscopo et al., 2009].  
As can be expected exostoses are only present in individuals with a deletion that extends to EXT1 
(Fig. 9). They can be present from the first month of life but some patients may not present the first 
exostosis until six years of age. The problems caused by exostoses are the same as in isolated inherited 
multiple exostoses [Hennekam 1991]. Joint dysplasia can be found at almost any joint but is by far most 
common in the hips and fingers. Clinical differentiation of the findings from rheumatoid arthritis can be 
difficult.  
  
Variability within families 
It is well known that TRPS can vary within families, even between MZ twins [Giedion et al., 1973; Naselli 
et al., 1998; Schinzel et al., 2013]. In the present series there are several families with multiple affected 
family members in whom this variability is mirrored (Fig. 11). The variability is present in all findings, 
both with respect to face morphology, ectodermal signs, growth, and clinical and radiological limb 
findings. In some family members recognition of TRPS may have been difficult if the proband or other 
affected family members would not have been available for comparison. Intra-familial variability as 
described here and in the literature [Giedion et al., 1973; Schinzel et al., 2013] forms further evidence 
that TRPS III represents one extreme of the clinical spectrum of TRPS I. In the present series no individual 
has been recognized to harbour a mutation in TRPS1 without showing any sign. As not all relatives of 
individuals with TRPS have been evaluated systematically for the presence of the mutation in the 
proband we cannot be sure non-penetrance does not occur at all, but present data indicate it must at 
least be low.  
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Genotypes 
The variation in TRPS1 mutations causing TRPS I is considerable. The location of missense mutations is 
limited to mainly exon 6 and sometimes exon 7 and of all other mutations to exon 4 to 7. A clear 
genotype – phenotype correlation was not present except for the obvious difference in occurrence of 
multiple exostoses and more marked intellectual disability in individuals with TRPS II. It may be that the 
more marked intellectual disability can be explained by the deletion of RAD21 in these patients. If the 
facial characteristics of such TRPS II individuals are compared to the characteristics of the Cornelia de 
Lange –like syndrome that can be caused by mutations in RAD21, a resemblance is often clear. The 
possible more marked facial and distal limb manifestations in individuals with mutations in exon 6 
compared to other exons remains uncertain at present. 
In literature several patients have been published as having TRPS II but without deletion of TRPS1 
[Pereza et al., 2012; McBrien et al., 2008, Wuyts et al., 2002). We re-evaluated the findings in these 
patients and question the diagnosis TRPS in all of these. It seems more likely the phenotype in these 
patients is explained by deletion of both EXT1 and RAD21 (located between TRPS1 and EXT1), which 
gives rise to a phenotype that resembles Cornelia de Lange syndrome [Deardorff et al., 2012; Chen et al., 
2013; Ansari et al., 2014].  
  
Conclusions 
This study presents the data of the largest group of individuals with TRPS published to date. The cardinal 
characteristics of TRPS are present in both patients with intragenic mutations and those with deletions of 
the whole gene. Differences between these two groups are limited except for the presence of multiple 
exostoses and level of cognitive functioning. The most notable diagnostic features are fine and/or sparse 
hair, the thickness and broadness of the medial part of the eyebrows compared to the remaining parts, 
the thickening of the columella, and the markedly variable shortening of metacarpal and metatarsal 
bones. Radiologically the cone-shaped epiphyses remain a hallmark. The natural history is dominated by 
the joint problems consisting of hypermobility and of the consequences of early osteoarthritis, mostly of 
the hips, but also of other large joints and the hands, and causing significant pain, disability and 
decreased mobility.  Intellectual disability is not common and only mild to moderate if present, except in 
the individuals with TRPS II where it is much more common but not universal. No clear genotype-
phenotype correlation was detectable in this cohort except for the exostoses and intellectual disability 
frequency in individuals with whole gene deletions. TRPS can vary within a family for all clinical findings.  
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Legends 
 
Table I. Table I. Growth and development in 103 patients with TRPS. 
 
Table II. Somatic problems in 103 patients with TRPS. 
 
Table III. Phenotype in 103 patients with TRPS. 
 
Table IV. Radiological findings in 103 patients with TRPS. 
 
Table V. Genotype in 103 patients with TRPS. 
 
Fig. 1. Phenotype in TRPS. Hair. A. Children. Note the variation in fine and sparsely implanted hair, and 
high anterior hair line. B. Adults. Note the fine hair, alopecia in some individuals (mainly males) but 
decrease in sparseness of hair in others (mainly females). The anterior hairline is invariably high. 
 
Fig. 2. Phenotype in TRPS. Eyebrow. Note the sometimes marked broadening of eyebrows, with sparse 
implantation in some but dense implantation in others. Except in the latter individuals there is a 
difference between the median one-third of the eyebrows compared to the latter two-third. 
 
Fig. 3. Phenotype in TRPS. Nose. Note the broad nasal tip and in some also abroad nasal ridge, but 
absence of broadening of the nasal bridge. The alae nasi are invariably underdeveloped which seems 
more marked in some individuals who have a low hanging columella as well. The columella can be 
extremely wide. The philtrum is long and indistinct. 
 
Fig. 4. Phenotype in TRPS. Dentition. Note irregular implantation of usually normally shaped and sized 
teeth, but retained primary teeth and abnormal shape in others.  
 
Fig. 5. Phenotype in TRPS. Ear. The ears are frequently large, and vary from normally shaped to 
overfolded helices to more marked malformed ears. 
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Fig. 6. Phenotype in TRPS. Hand. Note variability in shortening of the metacarpal bones, also between 
the hands of a single individual. Also individual metacarpals can be much more shortened than the 
others. Fingers can be ulnar and radially deviated.  
 
Fig. 7. Phenotype in TRPS. Foot. Note variably shortening of metatarsals, which can be limited to a single 
tarsal bone. Some of the depicted nails are dystrophic. 
 
Fig. 8. Phenotype in TRPS. Radiology of the distal limbs. Note cone-shaped epiphyses that are most 
common in the middle phalanx of the second digit, but can be present everywhere. Some radiographs 
show marked osteopenia.  
 
Fig. 9. Phenotype in TRPS. Multiple exostoses. Note that locations of visible exostoses are as in isolated 
multiple exostoses, i.e. mainly at sites with little tissue between bone and skin. Radiological 
characteristics are also similar to isolated multiple exostoses. 
 
Fig. 10. Genotype in 103 individuals with TRPS. Mutations occurring in more than a single individual are 
shown only once. Frameshift mutations are in blue, splice site mutations in brown, and missense 
mutations in black. The extension of the whole gene deletions to either site is not indicated as exact data 
were frequently lacking. Annotation according to reference sequence NM_014112.4. 
 
Fig. 11. Phenotype in TRPS. Intra-familial variability in three generations.  
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Table I. Growth and development in 103 patients with TRPS.  
 
           
All    TRPSI   TRPSI   TRPSII  
missense   other   deletions  
mutations     mutations     whole gene        
____________________________________________________________________________________________________________________________________________________________________ 
       n = 103*  n = 22   n =62   n =14 
____________________________________________________________________________________________________________________________________________________________________ 
Gender (M : F)      37/66   8/14   20/42   9/5 
   Mean age at last clinical evaluation   22.4 (1-74)  24.6 (1-73)  22.2 (1.5-67)  19.2 (4-65) 
   Mean paternal age at birth (n=30)   28.4 (19-44)  29 (19-38)  28 (21-44)  29.6 (21-41) 
   Mean maternal age at birth (n=30)   27.1 (20-37)  31 (27-35)  26,9 (20-37)  26.7 (20-32) 
Growth at birth 1,2 
   Length (cm)       48.8/49 (40.5-54) 49.9/50  (48-52) 47.5/49 (40.5-53) 48/45.8 (44-54)   
   Length at birth <-2SD      8/34    0/8   4/16   4/7 
   Length at birth >+2SD     2/34    0/8   0/16   2/7 
   Weight (g) 1      3162/3280   3385/3290  3269/3316  3051/3100  
(2440-4500)   (2800-4500)  (2500-4000)   (2440-3840) 
   Weight <-2SD (%)     8/68 (11)  0/15   7/43   1/7 
   Head circumference (cm)    34 / 33.5 (32-37) 34.4 / 34.5 (32-36.5) 35.3 / 35 (34-37) 33.6 / 33.3 (32-36) 
  Head circumference <-2SD     1/19    0/4   0/7   1/6 
Postnatal Growth1 
   Stature <-2SD adult male     15/22    4/6    6/11   5/5 
   Height (cm) adult male     158.3/158.9(138.5-173) 161.4/159,8 (153-171) 159.4/164.5 (139-173) 148.4/146.5 (138.5-157)  
   Stature <-2 SD adult female       22/44    10/10   10/31   2/2 
   Height (cm) adult female    153.4/155 (142-167) 151/151.5 (142-157) 155.2/155.8 (145-167)  149.5-149.5 (149-150)    
   Weight <-2SD (adults)     6/63   0/12   3/34   3/13 
   Head circumference adult male (cm)   56.1/56 (49-59)  57.5/57.5 (56-59) 56.3/55.3 (54-59) 54.5/55 (49-59) 
   Head circumference adult female (cm)   54.3/54.5 (48-57.5) 54.6/55 (52-57)  55/54.7 (52-57.5) 50/50 (48-52)  
   Head circumference <-2SD     6/69    2/14   0/47   3/6 
Development 
   Sitting age (months)1     8.9/8 (4-24)  8.6/8 (6-13)  9.1/8 (4-24)  9.3/9 (6-12) 
   Walking age (months)1     17.7/16 (9-72)  17.3/16,5 (8.5-24) 16.8/15 (9-42)  26.5/21 (14-72) 
   First words (months)1      16/13.5 (5-36)  19.5/19 (7-36)  14,9/12 (7-26)    16.8/15.5 (12-28) 
   Speech therapy      7/25    2/6   3/17   2/4 
   ID-mild vs moderate vs severe 3   11-2-1 (85)  1-0-0 (17)  5-0-1 (54)  5-2-0 (11) 
 
* includes five patients in whom exact nature of the mutations could not be determined and were not categorised in the three groups 
1 mean / median; between brackets range 
2 Only neonates born between 38-42 weeks were considered: weight: n= 28; length n=11; head circumference n=3  
3 Mild : IQ 50-69; moderate: IQ 35-49; Severe IQ <35 (IQ levels are estimates as formal testing has often not been performed); numbers between brackets: number of 
individuals with reliable data on cognitive functioning 
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Table II. Somatic problems in 103 patients with TRPS. 
 
All    TRPSI     TRPSI   TRPSII  
missense     other   deletions  
mutations    mutations            whole gene 
____________________________________________________________________________________________________________________________________________________________________________________________ 
       n = 103 (%)*  n = 22     n = 62   n = 14 
____________________________________________________________________________________________________________________________________________________________________________________________ 
Somatic problems 
   Seizures      8/94   (9)  1/18     2/56   4/13 
   Vison impairment     34/88 (39)  8/16     20/53   3/12 
   Hearing impairment     10/89 (11)  1/15     4/54   4/13 
   Dental overcrowding     48/71 (68)  11/14     26/40   6/10 
   Congenital cardiac anomaly    14/91 (15)  3/18     7/53   4/13 
   Respiratory problems     23/87 (26)  6/17     13/56   4/9 
   Frequent infections     37/88 (42)  6/18     23/52   5/11 
   Gastro-Oesophageal Reflux    11/83 (13)  3/15     2/53   4/9 
   Constipation      8/86   (9)  4/18     2/52   1/10 
   Renal anomaly      9/80 (11)  2/15     4/49   1/9 
   Menorrhagia1      6/33 (18)  2/8     3/21   0/1  
   Metrorrhagia1      1/20   (5)  0/4     0/13   0/1  
   Cryptorchidism     6/30 (20)  2/5     2/19   2/7 
   Fractures (range in number)    20/87 (23)  5/18 (1-3)    13/51 (1-more>5) 2/10 (both 1) 
   Mobility joints abnormal    38/63 (60)  7/11     21/38   8/9 
   Joint pains      22/34 (65)  7/9     12/20   3/5 
   Mobility (meters unaided); restricted   6/23 (26)  3/4     1/15   2/3 
   Hip surgery      7/65 (11)  2/15     2/35   2/10 
   Other joint/tendon surgery    18/93 (19)  3/18     10/59   3/11 
   Cancer      3/90   (3)  1/17     2/53   0/14 
   Premature aging     10/25 (40)  1/4     6/17   1/2 
 
* includes five patients in whom exact nature of the mutations could not be determined and were not categorised in the three groups   
1 only females >16 years of age 
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 Table III. Phenotype in 103 patients with TRPS. 
 
All    TRPSI   TRPSI   TRPSII  
missense   other   deletions  
mutations     mutations           whole gene  
_______________________________________________________________________________________________________________________________________________________________________ 
       n = 103 (%)*  n = 22   n = 62   n = 14 
_______________________________________________________________________________________________________________________________________________________________________ 
Craniofacial  
   Fine hair      90/96 (94)  20/21   55/58   12/13 
   Sparse hair      84/100 (84)  19/22   51/59   9/14 
   Depigmented hair     24/87 (28)  7/20   13/52   2/10 
   Eyebrows thick     27/93 (29)  7/20   13/57   7/13 
   Eyebrows broad     62/96 (65)  14/21   30/58   14/14  
   Large nose      82/97 (85)  20/22   50/58   8/13 
   Broad nasal septum     90/94 (96)  19/20   56/58   11/11 
   Broad nasal tip     99/102 (97)  21/22   59/61   14/14 
   Underdeveloped nasal alae    86/95 (91)  20/21   50/56   12/13 
   Long philtrum      92/102 (90)  15/22   59/61   13/13 
   Deep philtrum      18/95 (19)  2/21   7/55   6/14 
   Thin upper vermillion     80/99 (81)  16/21   51/59   10/14 
   Horizontal smile     64/76 (84)  14/16   38/43   7/10            
   Narrow palate      44/62 (71)  9/17   24/30   7/10  
   Micrognathia      23/100 (23)  3/21   11/61   7/14 
   Large ears      27/95 (28)  5/20   11/57   9/14 
   Prominent ears     31/96 (32)  5/20   14/59   10/13 
Limbs 
   Short metacarpals     58/93 (62)  20/21   28/56    7/12 
   Brachydactyly      65/99 (66)  22/22   33/61    7/12 
   Polydactyly      1/99 (1)  0/22   0/61    1/12 
   Dislocated patellae     9/64 (14)  2/15   3/37    1/8 
   Short feet      38/65 (58)  13/17   19/36    6/11 
   Short metatarsals     34/58 (59)  13/16   19/37    2/5 
   Dystrophic nails  
fingers      36/92 (39)  15/22   14/57      5/10 
    toes      41/71 (58)  14/18   19/43    6/8 
   Leg length discrepancy     10/45 (22)  1/10   4/28    5/6 
Trunk 
   Winged scapulae       17/58 (32)  4/14   6/33    4/8 
   Scoliosis      30/93 (32)  7/20   13/55    7/13   
   Small mammae      4/15  (36)    0/6    1/6     1/1   
 
* includes five patients in whom exact nature of the mutations could not be determined and were not categorised in the three groups 
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Table IV. Radiological findings in 103 patients with TRPS. 
 
All    TRPSI   TRPSI   TRPSII  
missense   other   deletions 
mutations     mutations               whole gene 
______________________________________________________________________________________________________________________________________________________________________________ 
       n = 103 (%)*  n = 22   n = 62   n = 14 
______________________________________________________________________________________________________________________________________________________________________________ 
 
   Cone shaped epiphysis     58/60 (97)  14/14   30/30   9/11 
    Fingers      37   10   23   3 
 Toes      15   5   9   1 
   Osteopenia       11/44 (25)  2/9   4/25   5/8 
   Exostoses      12/85 (14)  0/15   0/52   11/14 
   Exostoses, first noticed (months)1    33/28 (1-72)        27/36 (1-72) 
   Coxa plana      8/15 (53)  1/3   3/7   3/4 
   Hip dysplasia (u/b)2     18/38 (47)  4/5 (1/1)  6/21 (1/2)  7/8 (1/2) 
   Other joint dysplasia     9/28 (32)  4/9   5/15   0/3     
 
* includes five patients in whom exact nature of the mutations could not be determined and were not categorised in the three groups  
1 mean / median; between brackets range 
2 u=unilateral; b=bilateral 
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Table V. Genotype in 103 patients with TRPS#. 
 
Exon       deletion EXT1 nucleotide change amino acid change type of mutation  number of index patients  
_______________________________________________________________________________________________________________________________________________________________________________ 
2- 6  -  c.1-?_c.2700+?  -   deletion   1  
4  -  c.1010_1014dup p.(Cys339Glnfs*27 frameshift   1  
4  -  c.1093C>T  p.(Gln365*)  nonsense   1  
4  -  c.1105C>T  p.(Gln369*)  nonsense   1  
4  -  c.1176dup  p.(Asn393*)  nonsense   3   
4  -   c.1231dup  p.(Gln411Profs*11) frameshift   1  
4  -  c.1460del  p.Lys487Serfs*13 frameshift   1   
4  -  c.1630C>T  p.(Arg544*)  nonsense   3   
4  -  c.1870C>T  p.(Arg624*)  nonsense   2  
4  -  c.1882C>T  p.(Gln628*)  nonsense   1  
4  -  c.2094C>A  p.(Tyr698*)  nonsense   1   
5  -  c.2097-?_c.2700+?dup ?   ?    1  
5  -  c.2097-?_c.2700+?del ?   ?    2  
5  -  c.2179_2180del  p.(Val727Serfs*29) frameshift   1   
5  -  c.2355_2356del  p.(Lys786Glyfs*14) frameshift   1  
5  -  c.2394dup  p(.Ser799Glnfs2) frameshift   1   
5  -  c.2557C>T  p.(Arg853*)  nonsense   1   
6+7  -  c.2701-?_3885+?del ?   ?    2  
6  -   c.2731A>T  p.(Asn911Tyr)  missense   1  
6  -  c.2732A>G  p.(Asn911Ser)  missense   1  
6  -  c.2756T>C  p.(Leu919Pro)  missense   1  
6  -  c.2761 C>T  p.(Arg921*)  nonsense   2  
6  -  c.2762G>C  p.(Arg921Pro)  missense   3  
6  -  c.2762G>A  p.(Arg921Gln)  missense   2  
6  -  c.2783_2784insC p.(Val929Cysfs*22) frameshift   1  
6  -  c.2794G>A  p.(Ala932Thr)  missense   2 
6  -  c.2795C>T  p. (Ala932Val)  missense   2  
6  -  c.2801G>T  p.(Gly934Val)   missense   1  
intron 6  -  c.2823+1G>T  ?   ?    1  
intron 6  -  c.2824-23T>G  ?   ?    1  
7+?  -  c.2824-?_3885+?del ?   ?    1  
7  -  c.2852_2859dup p.(Gly954Lysfs*43) frameshift   1  
7  -  c.2942-2945del   p.(Glu994Glyfs*7) frameshift   1  
7  -  c.2893C>T  p.(Arg965Cys)  missense   2  
7  -  c.2894G>A   p.(Arg965His)  missense   1  
7  -  c.3077del  p.(Ser1026Thrfs*27) frameshift   1  
7  -  c.3140del  p.(Pro1047Leufs*6) frameshift   1  
7  -  c.3424del  p.(Ser1142Valfs*36) frameshift   1  
 
?  -  inv(8)(q13q24.1) ?   ?    1 
?  -  inv(8)(q21.1q24.1) ?   ?    1 
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deletion 1-7  -  deletion 8q23.1-q23.3 (7.52 Mb)       1   
deletion 1-7 -  deletion 8q23.1-q23.3 (109,381,001-117,488,105)(hg18)    1  
deletion 1-7  (-)*  “Whole TRPS1 deletion”        1   
deletion 1-7 (+)**  detected by FISH analysis       1 
deletion 1-7 (-)*  detected by FISH analysis       1  
deletion (+)**  deletion of one probe for LGS in MLPA P245     2  
deletion 1-7 +  deletion chr 8:108,448,738-121,747,270 (hg19)      1  
deletion 1-7 +  deletion chr8:108,700,000-120,800,000 (hg19)     1  
deletion 1-7 +  deletion chr8:113,858,753-119,323,017 (hg19)     1  
deletion 1-7 +  deletion chr8:114,255,657-134,634,824 (hg19)     1  
deletion 1-7 +  deletion 8q23.3-q24.1 (6.16 Mb)       2   
deletion 1-7 +  deletion 8q23.3-q24.12 (7.7 Mb)       1   
deletion 1-7 +  deletion chr8:116,002,879-121,241,253 (6,43Mb) (hg19)    1  
deletion 1-7 +  deletion chr8:116,493,571-120,223,875 (3,7 Mb) (hg19)    1  
 
#   Annotation according to reference sequence NM_014112.4 
*   insufficient molecular information but clinically no exostoses 
** insufficient molecular information but clinically multiple exostoses 
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